Pekin Hardy Strauss’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$863K Sell
9,963
-1,255
-11% -$120K 0.09% 231
2025
Q4
$1.08M Sell
11,218
-15,772
-58% -$1.53M 0.1% 189
2025
Q3
$2.57M Sell
26,990
-16,404
-38% -$1.51M 0.26% 100
2025
Q2
$3.78M Sell
43,394
-12,450
-22% -$1.06M 0.43% 62
2025
Q1
$5.02M Sell
55,844
-14,753
-21% -$1.32M 0.61% 46
2024
Q4
$5.64M Buy
70,597
+1,033
+1% +$89.4K 0.72% 40
2024
Q3
$6.26M Sell
69,564
-3,565
-5% -$300K 0.8% 31
2024
Q2
$5.76M Sell
73,129
-790
-1% -$64.8K 0.79% 32
2024
Q1
$6.44M Sell
73,919
-4,980
-6% -$425K 0.88% 28
2023
Q4
$6.5M Buy
78,899
+5,648
+8% +$430K 0.91% 27
2023
Q3
$5.74M Sell
73,251
-700
-0.9% -$58.6K 0.91% 26
2023
Q2
$6.52M Sell
73,951
-1,620
-2% -$139K 0.71% 25
2023
Q1
$6.09M Buy
75,571
+64,487
+582% +$5.26M 0.81% 27
2022
Q4
$861K Buy
11,084
+4,461
+67% +$362K 0.12% 164
2022
Q3
$535K Buy
6,623
+345
+5% +$31K 0.09% 183
2022
Q2
$563K Sell
6,278
-100
-2% -$10.1K 0.08% 194
2022
Q1
$708K Sell
6,378
-200
-3% -$21.1K 0.09% 195
2021
Q4
$680K Sell
6,578
-650
-9% -$75.3K 0.09% 198
2021
Q3
$906K Buy
7,228
+305
+4% +$39.5K 0.13% 173
2021
Q2
$859K Buy
6,923
+170
+3% +$21.3K 0.12% 174
2021
Q1
$798K Buy
6,753
+280
+4% +$32.8K 0.13% 158
2020
Q4
$758K Sell
6,473
-1,000
-13% -$110K 0.13% 147
2020
Q3
$777K Hold
7,473
0.16% 128
2020
Q2
$685K Buy
7,473
+1,000
+15% +$95.9K 0.15% 125
2020
Q1
$584K Sell
6,473
-600
-8% -$63.8K 0.13% 113
2019
Q4
$802K Buy
7,073
+300
+4% +$32.9K 0.13% 111
2019
Q3
$736K Hold
6,773
0.14% 111
2019
Q2
$660K Buy
6,773
+100
+1% +$9.13K 0.13% 115
2019
Q1
$608K Hold
6,673
0.05% 121
2018
Q4
$607K Hold
6,673
0.11% 111
2018
Q3
$656K Buy
6,673
+34
+0.5% +$3.14K 0.11% 118
2018
Q2
$568K Sell
6,639
-100
-1% -$8.35K 0.11% 118
2018
Q1
$541K Sell
6,739
-130
-2% -$10.7K 0.1% 119
2017
Q4
$555K Sell
6,869
-250
-4% -$20K 0.1% 115
2017
Q3
$554K Buy
7,119
+4,325
+155% +$359K 0.1% 116
2017
Q2
$248K Sell
2,794
-870
-24% -$73.4K 0.04% 157
2017
Q1
$295K Sell
3,664
-113
-3% -$8.83K 0.06% 143
2016
Q4
$269K Buy
3,777
+200
+6% +$15.7K 0.02% 141
2016
Q3
$309K Hold
3,577
0.05% 125
2016
Q2
$310K Sell
3,577
-50
-1% -$4.04K 0.07% 125
2016
Q1
$272K Buy
3,627
+50
+1% +$3.77K 0.06% 130
2015
Q4
$275K Sell
3,577
-295
-8% -$22.2K 0.06% 132
2015
Q3
$259K Hold
3,872
0.06% 129
2015
Q2
$287K Sell
3,872
-1,800
-32% -$138K 0.06% 128
2015
Q1
$442K Sell
5,672
-4,905
-46% -$372K 0.08% 91
2014
Q4
$764K Sell
10,577
-2,900
-22% -$201K 0.11% 125
2014
Q3
$835K Buy
13,477
+200
+2% +$12.7K 0.14% 64
2014
Q2
$847K Sell
13,277
-250
-2% -$15.2K 0.13% 63
2014
Q1
$832K Sell
13,527
-200
-1% -$11.7K 0.14% 60
2013
Q4
$788K Sell
13,727
-200
-1% -$11.3K 0.12% 63
2013
Q3
$742K Hold
13,927
0.12% 62
2013
Q2
$717K Buy
+13,927
New +$688K 0.12% 64

Other funds holding MDT

Pekin Hardy Strauss's MDT Position: Q1 2026 in Review

Pekin Hardy Strauss reduced its Medtronic (MDT) stake by 11% in Q1 2026, selling an estimated $120K and leaving 9,963 shares worth $863K. The position accounts for 0.09% of the portfolio, ranked #231.

Pekin Hardy Strauss first reported a position in MDT in Q2 2013 and has held it in 52 quarters since. The position peaked at $6.52M in Q2 2023. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • Pekin Hardy Strauss held 9,963 shares of Medtronic worth $863K as of Q1 2026.
  • Pekin Hardy Strauss sold 1,255 Medtronic shares in Q1 2026, an estimated $120K.
  • Medtronic made up 0.09% of Pekin Hardy Strauss's portfolio in Q1 2026, its #231 holding.
  • Pekin Hardy Strauss first reported a position in Medtronic in Q2 2013 and has held it in 52 quarters since.
  • Pekin Hardy Strauss's Medtronic position peaked at $6.52M in Q2 2023.
  • 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Pekin Hardy Strauss's 13F filing for Q1 2026, filed 7 May 2026.